Global Biologic Therapeutic Drug Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 07-Apr-2021
No. of pages: 107
Inquire Before Buying

Global Biologic Therapeutic Drug Scope and Market Size

Biologic Therapeutic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biologic Therapeutic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Monoclonal Antibodies

- Therapeutic Proteins

- Vaccines

Segment by Application

- Clinical Medicine

- Laboratory

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Aurobindo Pharma Ltd.

- Concord Biotech

- GlaxoSmithKline Plc.

- H. Lundbeck A/S

- Novartis Global

- Retractable Technologies, Inc.

- Smith Medical

- AstraZeneca

- Pfizer Inc.

- Merck and Co. Inc.

Global Biologic Therapeutic Drug Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic Therapeutic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Therapeutic Proteins
1.2.4 Vaccines
1.3 Market by Application
1.3.1 Global Biologic Therapeutic Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Medicine
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biologic Therapeutic Drug Market Perspective (2016-2027)
2.2 Biologic Therapeutic Drug Growth Trends by Regions
2.2.1 Biologic Therapeutic Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biologic Therapeutic Drug Historic Market Share by Regions (2016-2021)
2.2.3 Biologic Therapeutic Drug Forecasted Market Size by Regions (2022-2027)
2.3 Biologic Therapeutic Drug Industry Dynamic
2.3.1 Biologic Therapeutic Drug Market Trends
2.3.2 Biologic Therapeutic Drug Market Drivers
2.3.3 Biologic Therapeutic Drug Market Challenges
2.3.4 Biologic Therapeutic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic Therapeutic Drug Players by Revenue
3.1.1 Global Top Biologic Therapeutic Drug Players by Revenue (2016-2021)
3.1.2 Global Biologic Therapeutic Drug Revenue Market Share by Players (2016-2021)
3.2 Global Biologic Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biologic Therapeutic Drug Revenue
3.4 Global Biologic Therapeutic Drug Market Concentration Ratio
3.4.1 Global Biologic Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic Therapeutic Drug Revenue in 2020
3.5 Biologic Therapeutic Drug Key Players Head office and Area Served
3.6 Key Players Biologic Therapeutic Drug Product Solution and Service
3.7 Date of Enter into Biologic Therapeutic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic Therapeutic Drug Breakdown Data by Type
4.1 Global Biologic Therapeutic Drug Historic Market Size by Type (2016-2021)
4.2 Global Biologic Therapeutic Drug Forecasted Market Size by Type (2022-2027)
5 Biologic Therapeutic Drug Breakdown Data by Application
5.1 Global Biologic Therapeutic Drug Historic Market Size by Application (2016-2021)
5.2 Global Biologic Therapeutic Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biologic Therapeutic Drug Market Size (2016-2027)
6.2 North America Biologic Therapeutic Drug Market Size by Type
6.2.1 North America Biologic Therapeutic Drug Market Size by Type (2016-2021)
6.2.2 North America Biologic Therapeutic Drug Market Size by Type (2022-2027)
6.2.3 North America Biologic Therapeutic Drug Market Size by Type (2016-2027)
6.3 North America Biologic Therapeutic Drug Market Size by Application
6.3.1 North America Biologic Therapeutic Drug Market Size by Application (2016-2021)
6.3.2 North America Biologic Therapeutic Drug Market Size by Application (2022-2027)
6.3.3 North America Biologic Therapeutic Drug Market Size by Application (2016-2027)
6.4 North America Biologic Therapeutic Drug Market Size by Country
6.4.1 North America Biologic Therapeutic Drug Market Size by Country (2016-2021)
6.4.2 North America Biologic Therapeutic Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Biologic Therapeutic Drug Market Size (2016-2027)
7.2 Europe Biologic Therapeutic Drug Market Size by Type
7.2.1 Europe Biologic Therapeutic Drug Market Size by Type (2016-2021)
7.2.2 Europe Biologic Therapeutic Drug Market Size by Type (2022-2027)
7.2.3 Europe Biologic Therapeutic Drug Market Size by Type (2016-2027)
7.3 Europe Biologic Therapeutic Drug Market Size by Application
7.3.1 Europe Biologic Therapeutic Drug Market Size by Application (2016-2021)
7.3.2 Europe Biologic Therapeutic Drug Market Size by Application (2022-2027)
7.3.3 Europe Biologic Therapeutic Drug Market Size by Application (2016-2027)
7.4 Europe Biologic Therapeutic Drug Market Size by Country
7.4.1 Europe Biologic Therapeutic Drug Market Size by Country (2016-2021)
7.4.2 Europe Biologic Therapeutic Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biologic Therapeutic Drug Market Size (2016-2027)
8.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Type
8.2.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Application
8.3.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Biologic Therapeutic Drug Market Size by Region
8.4.1 Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biologic Therapeutic Drug Market Size (2016-2027)
9.2 Latin America Biologic Therapeutic Drug Market Size by Type
9.2.1 Latin America Biologic Therapeutic Drug Market Size by Type (2016-2021)
9.2.2 Latin America Biologic Therapeutic Drug Market Size by Type (2022-2027)
9.2.3 Latin America Biologic Therapeutic Drug Market Size by Type (2016-2027)
9.3 Latin America Biologic Therapeutic Drug Market Size by Application
9.3.1 Latin America Biologic Therapeutic Drug Market Size by Application (2016-2021)
9.3.2 Latin America Biologic Therapeutic Drug Market Size by Application (2022-2027)
9.3.3 Latin America Biologic Therapeutic Drug Market Size by Application (2016-2027)
9.4 Latin America Biologic Therapeutic Drug Market Size by Country
9.4.1 Latin America Biologic Therapeutic Drug Market Size by Country (2016-2021)
9.4.2 Latin America Biologic Therapeutic Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic Therapeutic Drug Market Size (2016-2027)
10.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Type
10.2.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Application
10.3.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Biologic Therapeutic Drug Market Size by Country
10.4.1 Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aurobindo Pharma Ltd.
11.1.1 Aurobindo Pharma Ltd. Company Details
11.1.2 Aurobindo Pharma Ltd. Business Overview
11.1.3 Aurobindo Pharma Ltd. Biologic Therapeutic Drug Introduction
11.1.4 Aurobindo Pharma Ltd. Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.1.5 Aurobindo Pharma Ltd. Recent Development
11.2 Concord Biotech
11.2.1 Concord Biotech Company Details
11.2.2 Concord Biotech Business Overview
11.2.3 Concord Biotech Biologic Therapeutic Drug Introduction
11.2.4 Concord Biotech Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.2.5 Concord Biotech Recent Development
11.3 GlaxoSmithKline Plc.
11.3.1 GlaxoSmithKline Plc. Company Details
11.3.2 GlaxoSmithKline Plc. Business Overview
11.3.3 GlaxoSmithKline Plc. Biologic Therapeutic Drug Introduction
11.3.4 GlaxoSmithKline Plc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.3.5 GlaxoSmithKline Plc. Recent Development
11.4 H. Lundbeck A/S
11.4.1 H. Lundbeck A/S Company Details
11.4.2 H. Lundbeck A/S Business Overview
11.4.3 H. Lundbeck A/S Biologic Therapeutic Drug Introduction
11.4.4 H. Lundbeck A/S Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.4.5 H. Lundbeck A/S Recent Development
11.5 Novartis Global
11.5.1 Novartis Global Company Details
11.5.2 Novartis Global Business Overview
11.5.3 Novartis Global Biologic Therapeutic Drug Introduction
11.5.4 Novartis Global Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.5.5 Novartis Global Recent Development
11.6 Retractable Technologies, Inc.
11.6.1 Retractable Technologies, Inc. Company Details
11.6.2 Retractable Technologies, Inc. Business Overview
11.6.3 Retractable Technologies, Inc. Biologic Therapeutic Drug Introduction
11.6.4 Retractable Technologies, Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.6.5 Retractable Technologies, Inc. Recent Development
11.7 Smith Medical
11.7.1 Smith Medical Company Details
11.7.2 Smith Medical Business Overview
11.7.3 Smith Medical Biologic Therapeutic Drug Introduction
11.7.4 Smith Medical Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.7.5 Smith Medical Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Biologic Therapeutic Drug Introduction
11.8.4 AstraZeneca Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Biologic Therapeutic Drug Introduction
11.9.4 Pfizer Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.9.5 Pfizer Inc. Recent Development
11.10 Merck and Co. Inc.
11.10.1 Merck and Co. Inc. Company Details
11.10.2 Merck and Co. Inc. Business Overview
11.10.3 Merck and Co. Inc. Biologic Therapeutic Drug Introduction
11.10.4 Merck and Co. Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021)
11.10.5 Merck and Co. Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biologic Therapeutic Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Therapeutic Proteins
Table 4. Key Players of Vaccines
Table 5. Global Biologic Therapeutic Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biologic Therapeutic Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Biologic Therapeutic Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Biologic Therapeutic Drug Market Share by Regions (2016-2021)
Table 9. Global Biologic Therapeutic Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Biologic Therapeutic Drug Market Share by Regions (2022-2027)
Table 11. Biologic Therapeutic Drug Market Trends
Table 12. Biologic Therapeutic Drug Market Drivers
Table 13. Biologic Therapeutic Drug Market Challenges
Table 14. Biologic Therapeutic Drug Market Restraints
Table 15. Global Biologic Therapeutic Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Biologic Therapeutic Drug Market Share by Players (2016-2021)
Table 17. Global Top Biologic Therapeutic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Therapeutic Drug as of 2020)
Table 18. Ranking of Global Top Biologic Therapeutic Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Biologic Therapeutic Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biologic Therapeutic Drug Product Solution and Service
Table 22. Date of Enter into Biologic Therapeutic Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biologic Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Biologic Therapeutic Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Biologic Therapeutic Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Biologic Therapeutic Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Biologic Therapeutic Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Biologic Therapeutic Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Biologic Therapeutic Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Biologic Therapeutic Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Biologic Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Biologic Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Biologic Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Biologic Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Biologic Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Biologic Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Biologic Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Biologic Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Biologic Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Biologic Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Biologic Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Biologic Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Biologic Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Biologic Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Biologic Therapeutic Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Biologic Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Biologic Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Biologic Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Biologic Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Biologic Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Biologic Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Biologic Therapeutic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Biologic Therapeutic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Biologic Therapeutic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. Aurobindo Pharma Ltd. Company Details
Table 63. Aurobindo Pharma Ltd. Business Overview
Table 64. Aurobindo Pharma Ltd. Biologic Therapeutic Drug Product
Table 65. Aurobindo Pharma Ltd. Revenue in Biologic Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 66. Aurobindo Pharma Ltd. Recent Development
Table 67. Concord Biotech Company Details
Table 68. Concord Biotech Business Overview
Table 69. Concord Biotech Biologic Therapeutic Drug Product
Table 70. Concord Biotech Revenue in Biologic Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 71. Concord Biotech Recent Development
Table 72. GlaxoSmithKline Plc. Company Details
Table 73. GlaxoSmithKline Plc. Business Overview
Table 74. GlaxoSmithKline Plc. Biologic Therapeutic Drug Product
Table 75. GlaxoSmithKline Plc. Revenue in Biologic Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 76. GlaxoSmithKline Plc. Recent Development
Table 77. H. Lundbeck A/S Company Details
Table 78. H. Lundbeck A/S Business Overview
Table 79. H. Lundbeck A/S Biologic Therapeutic Drug Product
Table 80. H. Lundbeck A/S Revenue in Biologic Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 81. H. Lundbeck A/S Recent Development
Table 82. Novartis Global Company Details
Table 83. Novartis Global Business Overview
Table 84. Novartis Global Biologic Therapeutic Drug Product
Table 85. Novartis Global Revenue in Biologic Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 86. Novartis Global Recent Development
Table 87. Retractable Technologies, Inc. Company Details
Table 88. Retractable Technologies, Inc. Business Overview
Table 89. Retractable Technologies, Inc. Biologic Therapeutic Drug Product
Table 90. Retractable Technologies, Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 91. Retractable Technologies, Inc. Recent Development
Table 92. Smith Medical Company Details
Table 93. Smith Medical Business Overview
Table 94. Smith Medical Biologic Therapeutic Drug Product
Table 95. Smith Medical Revenue in Biologic Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 96. Smith Medical Recent Development
Table 97. AstraZeneca Company Details
Table 98. AstraZeneca Business Overview
Table 99. AstraZeneca Revenue in Biologic Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Pfizer Inc. Company Details
Table 102. Pfizer Inc. Business Overview
Table 103. Pfizer Inc. Biologic Therapeutic Drug Product
Table 104. Pfizer Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 105. Pfizer Inc. Recent Development
Table 106. Merck and Co. Inc. Company Details
Table 107. Merck and Co. Inc. Business Overview
Table 108. Merck and Co. Inc. Biologic Therapeutic Drug Product
Table 109. Merck and Co. Inc. Revenue in Biologic Therapeutic Drug Business (2016-2021) & (US$ Million)
Table 110. Merck and Co. Inc. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologic Therapeutic Drug Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Therapeutic Proteins Features
Figure 4. Vaccines Features
Figure 5. Global Biologic Therapeutic Drug Market Share by Application: 2020 VS 2027
Figure 6. Clinical Medicine Case Studies
Figure 7. Laboratory Case Studies
Figure 8. Others Case Studies
Figure 9. Biologic Therapeutic Drug Report Years Considered
Figure 10. Global Biologic Therapeutic Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Biologic Therapeutic Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Biologic Therapeutic Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Biologic Therapeutic Drug Market Share by Regions (2022-2027)
Figure 14. Global Biologic Therapeutic Drug Market Share by Players in 2020
Figure 15. Global Top Biologic Therapeutic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Therapeutic Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Biologic Therapeutic Drug Revenue in 2020
Figure 17. Global Biologic Therapeutic Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Biologic Therapeutic Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Biologic Therapeutic Drug Market Share by Type (2016-2027)
Figure 21. North America Biologic Therapeutic Drug Market Share by Application (2016-2027)
Figure 22. North America Biologic Therapeutic Drug Market Share by Country (2016-2027)
Figure 23. United States Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biologic Therapeutic Drug Market Share by Type (2016-2027)
Figure 27. Europe Biologic Therapeutic Drug Market Share by Application (2016-2027)
Figure 28. Europe Biologic Therapeutic Drug Market Share by Country (2016-2027)
Figure 29. Germany Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biologic Therapeutic Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Biologic Therapeutic Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Biologic Therapeutic Drug Market Share by Region (2016-2027)
Figure 39. China Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Biologic Therapeutic Drug Market Share by Type (2016-2027)
Figure 47. Latin America Biologic Therapeutic Drug Market Share by Application (2016-2027)
Figure 48. Latin America Biologic Therapeutic Drug Market Share by Country (2016-2027)
Figure 49. Mexico Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Biologic Therapeutic Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Biologic Therapeutic Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Biologic Therapeutic Drug Market Share by Country (2016-2027)
Figure 55. Turkey Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Biologic Therapeutic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Aurobindo Pharma Ltd. Revenue Growth Rate in Biologic Therapeutic Drug Business (2016-2021)
Figure 59. Concord Biotech Revenue Growth Rate in Biologic Therapeutic Drug Business (2016-2021)
Figure 60. GlaxoSmithKline Plc. Revenue Growth Rate in Biologic Therapeutic Drug Business (2016-2021)
Figure 61. H. Lundbeck A/S Revenue Growth Rate in Biologic Therapeutic Drug Business (2016-2021)
Figure 62. Novartis Global Revenue Growth Rate in Biologic Therapeutic Drug Business (2016-2021)
Figure 63. Retractable Technologies, Inc. Revenue Growth Rate in Biologic Therapeutic Drug Business (2016-2021)
Figure 64. Smith Medical Revenue Growth Rate in Biologic Therapeutic Drug Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Biologic Therapeutic Drug Business (2016-2021)
Figure 66. Pfizer Inc. Revenue Growth Rate in Biologic Therapeutic Drug Business (2016-2021)
Figure 67. Merck and Co. Inc. Revenue Growth Rate in Biologic Therapeutic Drug Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
  • (Post-pandemic Era) - Global Vinpocetine Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 93
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Vinpocetine growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related regio......
  • (Post-pandemic Era) - Global Vinpocetine Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 115
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Vinpocetine Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 112
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Vaccine Adjuvants Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2021
    Published: 12-Apr-2021        Price: US 4860 Onwards        Pages: 85
    Summary This study analysis was given on a worldwide scale, for instance, present and historical Vaccine Adjuvants growth analysis, competitive analysis, and also the growth prospects of the major regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from production, revenue and consumption. A quantitative and qualitative analysis of the main players in related......
  • (Post-pandemic Era) - Global Vaccine Adjuvants Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 109
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Vaccine Adjuvants Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 109
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Saffron Extract Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
    Published: 12-Apr-2021        Price: US 3650 Onwards        Pages: 115
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Post-pandemic Era - Global Saffron Extract Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 12-Apr-2021        Price: US 3620 Onwards        Pages: 110
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Saffron Extract Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 12-Apr-2021        Price: US 3160 Onwards        Pages: 98
    Summary At the time of this report, many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. It should be noted that the impact of the epidemic has accelerated the trend of localization, regionalization and decentralization of the global industrial chain and supply chain, so it is inevitable to reconstruct the global industrial chain. Faced with the global industrial change in the post epidemic era, enterprises in var......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs